HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs

Sexually Transmitted Diseases

Volumn 35, Issue 7, 2008, Pages 696-702

  Miller, Maureen ^a   Liao, Yuyan ^b   Wagner, Meghan ^b   Korves, Caroline ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; DISEASE TRANSMISSION; DRUG USE; ENDEMIC DISEASE; FEMALE; GONORRHEA; HEALTH CARE UTILIZATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STRUCTURED QUESTIONNAIRE; SYPHILIS; TRICHOMONIASIS; ETHNOLOGY; MIDDLE AGED; NEGRO; QUESTIONNAIRE; STATISTICS; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; NEW YORK; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 50649114706     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816b1fb8     Document Type: Article

References (48)

1. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2005report/default.htm. Accessed November 2, 2007.
2. Available at: http://home2.nyc.gov/html/doh/downloads/pdf/dires/dires- 2005-report-semi2.pdf. Accessed November 2, 2007.
3. Centers for Disease Control and Prevention. Update: Trends in AIDS incidence-United States. MMWR Morb Mortal Wkly Rep 1997; 46:861-867.
4. Aral SO, Hughes JP, Whitttington W, et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health 1999; 89:825-833.
5. Eng TR, Butler WT. The Hidden Epidemic Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press, 1997.
6. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: A network explanation. Sex Transm Dis 1999; 26:250-261.
7. Smith DK, Gwinn M, Selik RM, et al. HIV/AIDS among African Americans: Progress or progression? AIDS 2000; 14:1237-1248.
8. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV and African-Americans. Emerg Infect Dis 2001; 7:927-932.
9. Cates W Jr., American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:S2-S7.
10. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17:794-803.
11. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
12. Laga M, Manoka A, Kivuvu M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
13. Reynolds SJ, Quinn TC. Developments in STD/HIV interations: The intertwining epidemics of HIV and HSV-2. Infect Dis Clin North Am 2005; 19:415-425.
14. Wasserheit JN. Interrelationships between human immunodeficiency viurs infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
15. Bozicevic I, Fenton K, Martin IMC, et al. Epidemiological correlates of asymptomatic gonorrhea. Sex Transm Dis 2006; 33:289-295.
16. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: An evidence update for the U.S. preventive services task force. Ann Intern Med 2007; 147:135-142.
17. Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141: 137-143.
18. Leone P. Reducing the risk of transmitting genital herpes: Advances in understanding and therapy. Curr Med Res Opin 2005 ; 21:1577-1582.
19. Hader SL, Smith DK, Moore JS, et al. HIV infection in women in the United States. JAMA 2001; 286:1186-1192.
20. Wechsberg WM, Lam WKK, Zule WA, et al. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health 2004; 94:1165-1173.
21. Miller M, Neaigus A. An economy of risk: Resource acquisition strategies of inner city women who use drugs. Int J Drug Policy 2002; 13:399-408.
22. Miller M, Korves CT, Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care 2007; 19:858 -865.
23. Wendel KA, Erbelding EJ, Gaydos CA, et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002; 35:576-580.
24. Hardick J, Yang S, Lin S, et al. Use of the Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J Infect Dis 2003; 41:5619 -5622.
25. Madico G, Quinn TC, Rompalo A, et al. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-3210.
26. Miller M, Cespedes C, Vavagiakis P, et al. Staphylococcus aureus colonization in a community sample of HIV infected and uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22:465-469.
27. Serwada D, Gray RH, Sewankambo NK. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: A nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188:1492-1497.
28. Van der Pol B. Trichomonas vaginalis infection: The most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44:23-25.
29. Plitt SS, Garfein RS, Gaydos CA, et al. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32:446-453.
30. Latka M, Ahern J, Garfein RS, et al; Collaborative Injection Drug User Study Group. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse 2001; 13:73-88.
31. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000; 31:920-926.
32. Brewer TH, Zhao W, Metsch LR, et al. High-risk behaviors in women who use crack: Knowledge of HIV serostatus and risk behavior. Ann Epidemiol 2007; 17:533-539.
33. Timpson SC, Williams ML, Bowen AM, et al. Condom use behaviors in HIV-infected African American crack cocaine users. Subst Abus 2003; 24:211-220.
34. Wilson TE, Gore ME, Greenblatt R, et al. Changes in sexual behavior among HIV-infected women after initiation of HAART. Am J Public Health 2004; 94:1141-1146.
35. Inciardi JA, Surratt HL, Kurtz SP, et al. The effect of serostatus on HIV risk behaviour change among women sex workers in Miami, Florida. AIDS Care 2005; 17:S88-S101.
36. Golub AL, Johnson BD. Crack's Decline: Some Surprises Across U.S. Cities. Research in Brief. Washington, DC: National Institute of Justice, 1997.
37. Ratner MS, ed. Crack Pipe as Pimp: An Ethnographic Investigation of Sex-for-Crack Exchanges. New York: Lexington Books, 1993.
38. Aral SO, Lipshutz J, Blanchard J. Drivers of STD/HIV epidemiology and the timing and targets of STD/HIV prevention. Sex Transm Dis 2007; 83:i1-i4.
39. Marmot M. The Status Syndrome: How Social Standing Affects Our Health and Longevity. New York: Henry Holth and Company, 2004.
40. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: Implications for prevention strategies. J Infect Dis 1996; 174:S201-S213.
41. Zenilman JM, Ellish N, Fresia A, et al. The geography of sexual partnerships in Baltimore: Applications of core theory dynamics using a geographic information system. Sex Transm Dis 1999; 26:75-81.
42. Miller M, Liao Y, Manchikanti-Gomez A, et al. Prevalence and incidence rates of Trichomonas vaginalis among African American women in New York City who use drugs. J Infect Dis. 2008; 197(4): 503-509.
43. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007; 45:194-198.
44. Gaydos CA. Rapid tests for sexually transmitted diseases. Curr Infect Dis Rep 2006; 8:115-124.
45. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Incorporating HIV prevention into the medical care of persons living with HIV. MMWR Recomm Rep 2003; 52(RR-12):1-24.
46. Miller M. The dynamics of substance use and sex networks in HIV transmission. J Urban Health 2003 ; 80:iii88-iii96.
47. Heckathorn D. Respondent driven sampling: A new approach to the study of hidden populations. Soc Probl 1997; 44:174-199.
48. Thompson SK, Seber GAF. Adaptive Sampling. New York, NY: John Wiley and Sons, 1996.